Fig. 4

Cost-effectiveness acceptability curves at different thresholds of willingness to pay ABE + ET: abemaciclib + endocrine therapy; ET: endocrine therapy
Cost-effectiveness acceptability curves at different thresholds of willingness to pay ABE + ET: abemaciclib + endocrine therapy; ET: endocrine therapy